Piccillo Ellen M, Farsar Cameron J, Holmes David M
Otolaryngology, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, USA.
Surgery, University of Connecticut Health, Farmington, USA.
Cureus. 2023 Mar 19;15(3):e36371. doi: 10.7759/cureus.36371. eCollection 2023 Mar.
Orofacial clefts are common congenital deformities. Global initiatives have increased access to cleft care and reconstruction surgeries for cleft lip with or without cleft palate (CL/P), but there is no consensus on the use of postoperative prophylactic antibiotics. We conducted a narrative review using PubMed on the use of postoperative prophylactic antibiotics in CL/P surgery. A search of PubMed identified 30 potentially relevant articles, of which 15 were reviewed. There was no consensus among surgeons on prescribing patterns, but there was limited evidence that postoperative antibiotics reduce palatal fistulas. Notably, microbiological screening is not used to guide the choice of antimicrobial or to predict postoperative complications. Based on limited available data, we cannot make any strong evidence-based recommendations on prescribing postoperative antibiotics; however, we recommend that each cleft surgeon performing these procedures in lower-income countries without access to tertiary care centers consider the cost-benefit analysis of prescribing antimicrobials postoperatively, without antimicrobial screening, which showed no benefit.
口腔颌面裂是常见的先天性畸形。全球倡议增加了唇裂伴或不伴腭裂(CL/P)患者获得唇裂治疗和重建手术的机会,但对于术后预防性抗生素的使用尚无共识。我们使用PubMed对CL/P手术中术后预防性抗生素的使用进行了叙述性综述。在PubMed上搜索到30篇可能相关的文章,其中15篇进行了综述。外科医生在处方模式上没有达成共识,但仅有有限的证据表明术后抗生素可减少腭瘘。值得注意的是,微生物学筛查未被用于指导抗菌药物的选择或预测术后并发症。基于有限的现有数据,我们无法就术后开具抗生素提出任何强有力的循证建议;然而,我们建议,在没有三级护理中心的低收入国家进行这些手术的每位唇裂外科医生,考虑在不进行抗菌药物筛查的情况下术后开具抗菌药物的成本效益分析,结果显示并无益处。